πŸ‡ΊπŸ‡Έ FDA
Patent

US 8455497

Inhibitors of aspartyl protease

granted A61KA61K31/352A61K31/36

Quick answer

US patent 8455497 (Inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/352, A61K31/36, A61K45/06, A61P